Rigel Pharmaceuticals
RIGL
RIGL
158 hedge funds and large institutions have $430M invested in Rigel Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 72 increasing their positions, 48 reducing their positions, and 48 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
38% less capital invested
Capital invested by funds: $691M → $430M (-$261M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
65% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 48
Holders
158
Holding in Top 10
1
Calls
$2.28M
Puts
$1.41M
Top Buyers
| 1 | +$14.9M | |
| 2 | +$9.74M | |
| 3 | +$5.81M | |
| 4 |
Two Sigma Investments
New York
|
+$4.52M |
| 5 |
BlackRock
New York
|
+$3.52M |
Top Sellers
| 1 | -$12.1M | |
| 2 | -$9.75M | |
| 3 | -$8.28M | |
| 4 |
Goldman Sachs
New York
|
-$7.82M |
| 5 |
Jane Street
New York
|
-$6.91M |
